Clinical trial
A Research Study Looking at Mim8 in Children With Haemophilia A With or Without…
NCT05306418 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT05306418 |
|---|---|
| Title | A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors |
| Official title | Safety, Efficacy and Exposure of Subcutaneously Administered NNC0365-3769 (Mim8) Prophylaxis in Children With Haemophilia A With or Without FVIII Inhibitors |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Haemophilia A With or Without Inhibitors |
| Intervention type | Drug |
| Interventions | Mim8 |
| Enrollment | 70 |
| Start date | Apr 4, 2022 |
| Primary completion | Nov 13, 2024 |
| Completion | Nov 13, 2024 |
| First posted | Apr 1, 2022 |
| Last update posted | Nov 13, 2025 |
| Countries | Canada, China, Germany, India, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Portugal, Russia and 7 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: